Compare StocksABBV vs LII

AbbVie Inc. (ABBV) vs Lennox International, Inc. (LII): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. LII is undervalued at $416, with an intrinsic value of $557 and a margin of safety of 25%. Of the two, LII has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
LII
Lennox International, Inc.
$415.88

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
LII
  • Lennox International, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Lennox International, Inc. scores 74/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • Free cash flow has grown at a 47.0% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
LII
  • High leverage (1.52x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • Beneish M-Score of -1.37 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.
  • 8 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
LII
Valuation
N/A
Free Cash Flow
$638.80M
N/A
FCF Yield
4.44%
70.89
Trailing P/E
18.48
15.41
Forward P/E
15.80
Quality & Moat
27.60%
ROIC
28.82%
N/A
ROE
71.76%
72.79%
Gross Margin
33.33%
0.41
PEG Ratio
1.25
Balance Sheet Safety
N/A
Net Debt / Equity
1.52
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
1.68
2.76%
Dividend Yield
1.31%
ABBV: 3Ties: 3LII: 2
ABBVLII

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

LII

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
LII
$4.89
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.72B
Δ Market Cap
+$8.41B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
LII
25.3% Margin of Safety
Price is 25.3% below estimated fair value
Current Price: $415.88
Fair Value: $556.65
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

LII

What growth rate is the market pricing in at $416?

+7.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.1%

The market implies +7.9% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +11.1%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
LII
74/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by reinvestment efficiency. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
LII
-1.37
Likely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
LII
Insiders 9.6%Institutions 79.9%Retail & Other 10.5%
No. of Institutional Holders946
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
LII
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
LII
1
Sells (3M)
8
Sells (12M)
Total value (12M): $2.45M
KOSEL CHRIS A
Officer
$529,001
@ $544.80 · 2026-05-06
WALL SHANE D.
Director
$54,001
@ $540.01 · 2026-02-25
KOSEL CHRIS A
Officer
$136,271
@ $536.50 · 2026-02-04
TESKE TODD J
Director
$373,415
@ $533.45 · 2026-02-04
TESKE TODD J
Director
$295,110
@ $491.85 · 2025-11-11
KOSEL CHRIS A
Officer
$177,558
@ $591.86 · 2025-08-22
QUINTOS KAREN H.
Director
$657,665
@ $607.82 · 2025-08-20
QUINTOS KAREN H.
Director
$222,394
@ $609.30 · 2025-08-20
SESSA DANIEL M
Officer
$1.86M
@ $670.04 · 2025-07-23
NORRIS JOHN W III
Director
$14.88M
@ $666.20 · 2025-07-23
NORRIS JOHN W III
Director
$1.96M
@ $613.72 · 2025-07-10
NORRIS JOHN W III
Director
$1.93M
@ $606.00 · 2025-07-03
NORRIS JOHN W III
Director
$1.91M
@ $600.00 · 2025-07-01
KOSEL CHRIS A
Officer
$289,140
@ $568.06 · 2025-05-07
KOSEL CHRIS A
Officer
$124,975
@ $644.20 · 2025-02-21
TORRES JOHN D
Officer
$1.04M
@ $582.55 · 2025-02-04
BUCK SHERRY L
Director
$330,370
@ $660.74 · 2024-11-27
TESKE TODD J
Director
$337,760
@ $675.52 · 2024-11-25
KOSEL CHRIS A
Officer
$125,098
@ $625.49 · 2024-11-13
BEDAPUDI PRAKASH
Chief Technology Officer
$596,370
@ $618.00 · 2024-11-05
NASSAB JOSEPH
Officer
$398,091
@ $619.12 · 2024-11-05
WALL SHANE D.
Director
$199,215
@ $612.97 · 2024-10-28
TORRES JOHN D
Officer
$360,789
@ $620.98 · 2024-10-25
BEDAPUDI PRAKASH
Chief Technology Officer
$3.14M
@ $584.00 · 2024-08-28
BUCK SHERRY L
Director
$291,735
@ $583.47 · 2024-08-23
QUINTOS KAREN H.
Director
$1.02M
@ $574.87 · 2024-08-20
NORRIS JOHN W III
Director
$976,412
@ $574.36 · 2024-08-20
BEDAPUDI PRAKASH
Chief Technology Officer
$1.98M
@ $578.00 · 2024-08-19
BEDARD GARY S
Officer
$685,351
@ $576.41 · 2024-08-19
WALL SHANE D.
Director
$201,831
@ $576.66 · 2024-08-19
TESKE TODD J
Director
$1.15M
@ $574.05 · 2024-08-19
SESSA DANIEL M
Officer
$7.68M
@ $570.97 · 2024-08-16
TORRES JOHN D
Officer
$4.12M
@ $571.21 · 2024-08-16
NASSAB JOSEPH
Officer
$664,195
@ $570.12 · 2024-08-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
LII
FearGreed
🥶Extreme Fear(15/100)

"Mr. Market is panicking — potential buying opportunity if fundamentals are strong"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
LII
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Extreme Fear (15)
View ABBV Full AnalysisView LII Full Analysis

Frequently Asked Questions: ABBV vs LII

Is AbbVie Inc. or Lennox International, Inc. more undervalued in 2026?

Based on our discounted cash flow model, LII trades at a 25.3% margin of safety (intrinsic value $557 vs. price $416), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

Which stock has a wider economic moat, AbbVie Inc. or Lennox International, Inc.?

ABBV scores 82/100 (Wide moat), while LII scores 74/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. LII scores 7.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Lennox International, Inc.?

LII earns 28.8% ROIC versus ABBV's 27.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Lennox International, Inc.'s?

LII's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). LII has raised its dividend for 3 consecutive years.

Does Lennox International, Inc. have accounting red flags?

LII's Beneish M-Score of -1.4 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, ABBV scores -2.9, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.